Fidelity Investments’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$139K Buy
30,868
+1,607
+5% +$7.25K ﹤0.01% 3468
2025
Q1
$130K Sell
29,261
-22,461
-43% -$99.5K ﹤0.01% 3444
2024
Q4
$405K Buy
51,722
+15,306
+42% +$120K ﹤0.01% 3003
2024
Q3
$479K Buy
36,416
+6,822
+23% +$89.7K ﹤0.01% 2869
2024
Q2
$357K Buy
29,594
+1,628
+6% +$19.7K ﹤0.01% 2839
2024
Q1
$455K Sell
27,966
-8,876
-24% -$144K ﹤0.01% 2754
2023
Q4
$251K Buy
36,842
+767
+2% +$5.23K ﹤0.01% 2889
2023
Q3
$197K Sell
36,075
-897
-2% -$4.89K ﹤0.01% 2895
2023
Q2
$251K Buy
36,972
+35,662
+2,722% +$242K ﹤0.01% 2882
2023
Q1
$6.56K Buy
1,310
+108
+9% +$541 ﹤0.01% 4294
2022
Q4
$5.87K Sell
1,202
-1,377,264
-100% -$6.72M ﹤0.01% 4200
2022
Q3
$19.9M Sell
1,378,466
-592,385
-30% -$8.54M ﹤0.01% 1611
2022
Q2
$29.8M Buy
1,970,851
+583
+0% +$8.82K ﹤0.01% 1484
2022
Q1
$23.4M Buy
1,970,268
+444,481
+29% +$5.28M ﹤0.01% 1714
2021
Q4
$24.7M Hold
1,525,787
﹤0.01% 1729
2021
Q3
$43.5M Sell
1,525,787
-23,200
-1% -$662K ﹤0.01% 1469
2021
Q2
$52.4M Hold
1,548,987
﹤0.01% 1405
2021
Q1
$46.8M Buy
1,548,987
+541,813
+54% +$16.4M ﹤0.01% 1436
2020
Q4
$49.9M Sell
1,007,174
-107,468
-10% -$5.32M ﹤0.01% 1325
2020
Q3
$42.8M Sell
1,114,642
-196,100
-15% -$7.53M ﹤0.01% 1252
2020
Q2
$56.6M Sell
1,310,742
-80,100
-6% -$3.46M 0.01% 1113
2020
Q1
$36.3M Sell
1,390,842
-219
-0% -$5.72K 0.01% 1151
2019
Q4
$43.5M Sell
1,391,061
-235,581
-14% -$7.36M ﹤0.01% 1264
2019
Q3
$42.4M Hold
1,626,642
0.01% 1240
2019
Q2
$37.2M Hold
1,626,642
﹤0.01% 1359
2019
Q1
$42.6M Hold
1,626,642
0.01% 1280
2018
Q4
$33.1M Buy
1,626,642
+396,000
+32% +$8.05M ﹤0.01% 1343
2018
Q3
$32.7M Buy
+1,230,642
New +$32.7M ﹤0.01% 1480